SCOTTSDALE, Ariz., March 12,
2024 /PRNewswire/ -- LifeStance Health, one of the
nation's largest providers of virtual and in-person outpatient
mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of
directors. Dr. DeLuca is a psychiatrist and accomplished physician
executive with over 20 years of leadership experience, having held
senior executive leadership roles at Magellan Health, Humana and
Walgreens, and brings extensive healthcare operations and clinical
management expertise to LifeStance's board of directors.
"Dr. DeLuca's background as a tenured healthcare executive and
practicing psychiatrist make her a tremendous addition to our board
of directors," said Ken Burdick,
Chairman and CEO, LifeStance. "As an organization focused on
clinical quality and delivering exceptional patient outcomes, I'm
confident that her skills and expertise will be a strong complement
to our current board as we continue to expand access to much needed
mental healthcare across the country."
"As the leader in comprehensive, high-quality mental healthcare,
LifeStance is truly making a difference in the lives of its
patients while also meaningfully addressing the growing mental
health crisis," said Dr. DeLuca. "I'm thrilled to join the
organization as it continues to advance its mission, and I look
forward to working alongside Ken and the board of directors at
LifeStance to help even more patients receive the personalized care
they need."
Dr. DeLuca most recently served as Managing Director of
Columbia University's NY Life Science
Venture, which focused on bringing life sciences research and
promising early-stage technologies to market. Previously, she was
the Chief Medical Officer at Magellan Health where she spearheaded
first-to-market products and technologies, including integrating
behavioral health data with pharmacy claims and clinical
management. Prior to Magellan Health, Dr. DeLuca served as SVP,
Health Solutions at Humana, where she oversaw sales, operations and
clinical management. She currently serves on the Board of Directors
for Surgery Partners and Rejuveron. Dr. DeLuca received an MBA from
Drexel University's LeBow College of Business and her medical degree
from Thomas Jefferson University.
ABOUT LIFESTANCE HEALTH
Founded in 2017, LifeStance
(NASDAQ: LFST) is reimagining mental health. We are one of the
nation's largest providers of virtual and in-person outpatient
mental healthcare for children, adolescents and adults experiencing
a variety of mental health conditions. Our mission is to help
people lead healthier, more fulfilling lives by improving access to
trusted, affordable and personalized mental healthcare. LifeStance
employs approximately 6,600 psychiatrists, advanced practice
nurses, psychologists and therapists and operates across 33 states
and more than 550 centers. To learn more, please visit
www.LifeStance.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lifestance-appoints-dr-teresa-deluca-to-board-of-directors-302086204.html
SOURCE LifeStance Health